Previous studies have demonstrated that increasing the levels of EETs by inhibiting soluble epoxide hydrolase confers cardioprotection against Ang II‐induced cardiac hypertrophy (Ai et al., 2009), but the mechanisms of this action were unclear. The gene discussed is AGT; the disease is cardiac hypertrophy.